SOUTH SAN FRANCISCO, CA--(MARKET WIRE)--Sep 13, 2007 -- Theravance, Inc. (NasdaqGM:THRX - News) today announced that the period during which holders of its common stock could require Theravance, using funds provided by GlaxoSmithKline plc (NYSE:GSK - News), to redeem up to 50% of their shares of common stock for $19.375 per share (the "Put Right") expired at 5:00 p.m. EDT on September 12, 2007 (the "Expiration Time").
